Breakwater Capital Group Abbott Laboratories Transaction History

Breakwater Capital Group

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$100.73 - $112.44 $5,439 - $6,071	-54 Reduced 1.99%	2,662 $277 Million
Q4 2023 Jan 23, 2024	BUY	$90.19 - $110.4 $2,254 - $2,760	25 Added 0.93%	2,716 $310 Million
Q3 2023 Nov 03, 2023	BUY	$95.53 - $114.62 $27,226 - $32,666	285 Added 11.85%	2,691 $256 Million
Q2 2023 Jul 24, 2023	SELL	$100.78 - $112.29 $3,930 - $4,379	-39 Reduced 1.6%	2,406 $262 Million
Q1 2023 Apr 26, 2023	BUY	$96.86 - $114.01 $9,492 - $11,172	98 Added 4.18%	2,445 $248 Million
Q4 2022 Feb 02, 2023	BUY	$95.06 - $111.52 $223,105 - $261,737	2,347 New	2,347 $258 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Breakwater Capital Group, based on Form 13F filings with the SEC.

Stay updated on Breakwater Capital Group with notifications on news.